InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Sorensen Mel. Officer active across 1 company, notably Galera Therapeutics, Inc.. Aggregated, 2 filings have been logged. Split: 1 buy · 1 sell. Total volume traded: €163k. History available since 10 March 2023. The latest transaction was filed on 16 August 2024 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations